This study aimed to evaluate the postoperative and intermediate outcomes of thoracic endovascular aortic repair (TEVAR) in patients with end-stage renal disease (ESRD).
Methods
We retrospectively reviewed patients with type B aortic dissection (TBAD) undergoing TEVAR at our single center from January 2010 to December 2020. Patients with pre-existing ESRD were enrolled as the study group. One hundred consecutive patients from September 2013 to March 2015 without ESRD were included as the control group. The primary and secondary outcomes were adverse events and survival, respectively. Kaplan–Meier curves of survival and freedom from adverse events were calculated and analyzed using the log-rank univariate test. Multivariable analysis was used to isolate the effects of ESRD.
Results
A total of 39 patients with ESRD and TBAD underwent TEVAR during the study period. The median follow-up time of patients with and without ESRD was 45 and 46 months, respectively. There was significant difference between the survival at 4 years of patients with and without ESRD (72.8% vs 94.9%; p = 0.011). Meanwhile, the incidence of adverse events was significantly higher in patients with ESRD (p = 0.026). Multivariable logistic regression analysis showed that ESRD (OR, 2.46; p = 0.049) and peripheral artery disease (OR, 4.11; p = 0.002) were the predictors of adverse events.
Conclusions
The rates of adverse events and survival expectancy were poor in patients with ESRD and TBAD.
SeyedghasemiNSBahrampourAEtminanA, et al.Estimating the Loss in Expectation of Life and Relative Survival Rate among Hemodialysis Patients in Iran. J Res Health Sci2020; 20: e00487.
2.
CanaudBKoomanJPSelbyNM, et al.Dialysis-Induced Cardiovascular and Multiorgan Morbidity. Kidney Int Rep2020; 5: 1856–1869.
3.
KandaHHirasakiYIidaT, et al.Perioperative Management of Patients With End-Stage Renal Disease. J Cardiothorac Vasc Anesth2017; 31: 2251–2267. DOI: 10.1053/j.jvca.2017.04.019.
4.
BenjaminEJViraniSSCallawayCW, et al.Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation2018; 137: e67–e492. DOI: 10.1161/cir.0000000000000558.
5.
IwataTMoriT. Long-term Clinical Outcomes of Elective Carotid Artery Stenting in Patients Undergoing Maintenance Hemodialysis. Intern Med2020; 59: 479–483.
6.
KawahitoKAizawaKOkiS, et al.Heart valve surgery in hemodialysis-dependent patients: nutrition status impact on surgical outcome. J Artif Organs2016; 19: 134–140. DOI: 10.1007/s10047-015-0883-4.
7.
MorishitaKKawaharadaNFukadaJ, et al.Midterm results of surgical treatment of thoracic aortic disease in dialysis patients. Ann Thorac Surg2005; 80: 96–100. DOI: 10.1016/j.athoracsur.2005.01.055.
8.
StevensPELevinA. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med2013; 158: 825–830. DOI: 10.7326/0003-4819-158-11-201306040-00007.
9.
ErbelRAboyansVBoileauC, et al.ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J2014; 35: 2873–2926. DOI: 10.1093/eurheartj/ehu281.
10.
RiambauVBöcklerDBrunkwallJ, et al.Editor’s Choice - Management of Descending Thoracic Aorta Diseases: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg2017; 53: 4–52. DOI: 10.1016/j.ejvs.2016.06.005.
11.
MacGillivrayTEGleasonTGPatelHJ, et al.The Society of Thoracic Surgeons/American Association for Thoracic Surgery Clinical Practice Guidelines on the Management of Type B Aortic Dissection. Ann Thorac Surg2022; 113: 1073–1092. DOI: 10.1016/j.athoracsur.2021.11.002.
12.
LombardiJVHughesGCAppooJJ, et al.Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) Reporting Standards for Type B Aortic Dissections. Ann Thorac Surg2020; 109: 959–981. DOI: 10.1016/j.athoracsur.2019.10.005.
13.
ShuXXuHWangE, et al.Midterm outcomes of an adjustable puncture device for in situ fenestration during thoracic endovascular aortic repair. Eur J Vasc Endovasc Surg2022; 63: 43–51. DOI: 10.1016/j.ejvs.2021.09.028.
14.
WheelerDCStefanssonBVBatiushinM, et al.The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Nephrol Dial Transplant2020; 35: 1700–1711.
15.
YamagataKYagisawaTNakaiS, et al.Prevalence and incidence of chronic kidney disease stage G5 in Japan. Clin Exp Nephrol2015; 19: 54–64. DOI: 10.1007/s10157-014-0978-x.
16.
JohansenKLGarimellaPSHicksCW, et al.Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int2021; 100: 35–48. DOI: 10.1016/j.kint.2021.04.029.
17.
SungPHYangYHChiangHJ, et al.Risk of aortic aneurysm and dissection in patients with autosomal-dominant polycystic kidney disease: a nationwide population-based cohort study. Oncotarget2017; 8: 57594–57604.
18.
IwakoshiSDakeMDIrieY, et al.Management of Renal Arteries in Conjunction with Thoracic Endovascular Aortic Repair for Complicated Stanford Type B Aortic Dissection: The Japanese Multicenter Study (J-Predictive Study). Radiology2020; 294: 455–463. DOI: 10.1148/radiol.2019190598.
19.
MarleviDSoteloJAGrogan-KaylorR, et al.False lumen pressure estimation in type B aortic dissection using 4D flow cardiovascular magnetic resonance: comparisons with aortic growth. J Cardiovasc Magn Reson2021; 23: 51. DOI: 10.1186/s12968-021-00741-4.
20.
BondessonJSuhGYMarksN, et al.Influence of thoracic endovascular aortic repair on true lumen helical morphology for Stanford type B dissections. J Vasc Surg2021; 74: 1499–1507. DOI: 10.1016/j.jvs.2021.04.029.
21.
OtakiYWatanabeTKontaT, et al.Impact of Chronic Kidney Disease on Aortic Disease-related Mortality: A Four-year Community-Based Cohort Study. Intern Med2021; 60: 689–697.
22.
ReutersbergBSalvermoserMTrennerM, et al.Hospital Incidence and In-Hospital Mortality of Surgically and Interventionally Treated Aortic Dissections: Secondary Data Analysis of the Nationwide German Diagnosis-Related Group Statistics From 2006 to 2014. J Am Heart Assoc2019; 8: e011402.
23.
LimCY. Endovascular Repair in Acute Complicated Type B Aortic Dissection: 3-Year Results from the Valiant US Investigational Device Exemption Study. Korean J Thorac Cardiovasc Surg2017; 50: 137–143.
24.
ChenYZhangSLiuL, et al.Retrograde Type A Aortic Dissection After Thoracic Endovascular Aortic Repair: A Systematic Review and Meta-Analysis. J Am Heart Assoc2017; 6: e004649.
25.
LandenhedMEngströmGGottsäterA, et al.Risk profiles for aortic dissection and ruptured or surgically treated aneurysms: a prospective cohort study. J Am Heart Assoc2015; 4: e001513.
26.
AziziMSchmiederREMahfoudF, et al.Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet2018; 391: 2335–2345. DOI: 10.1016/s0140-6736(18)31082-1.
27.
KandzariDEBöhmMMahfoudF, et al.Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet2018; 391: 2346–2355. DOI: 10.1016/s0140-6736(18)30951-6.
28.
WeiXBWangYLuoJF, et al.Utility of age, creatinine, and ejection fraction score in patients with type B aortic dissection undergoing thoracic endovascular aortic repair. Int J Cardiol2020; 303: 69–73. DOI: 10.1016/j.ijcard.2019.09.076.
29.
SchiffrinELLipmanMLMannJF. Chronic kidney disease: effects on the cardiovascular system. Circulation2007; 116: 85–97. DOI: 10.1161/circulationaha.106.678342.
30.
XieJZengSXieL, et al.Differences in the clinical presentation, management, and in-hospital outcomes of acute aortic dissection in patients with and without end-stage renal disease. BMC Nephrol2021; 22: 257.
31.
HarnettJDFoleyRNKentGM, et al.Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int1995; 47: 884–890. DOI: 10.1038/ki.1995.132.
32.
WangGJJacksonBMFoleyPJ, et al.National trends in admissions, repair, and mortality for thoracic aortic aneurysm and type B dissection in the National Inpatient Sample. J Vasc Surg2018; 67: 1649–1658. DOI: 10.1016/j.jvs.2017.09.050.
33.
LiuDLuoHLinS, et al.Comparison of the efficacy and safety of thoracic endovascular aortic repair with open surgical repair and optimal medical therapy for acute type B aortic dissection: A systematic review and meta-analysis. Int J Surg2020; 83: 53–61. DOI: 10.1016/j.ijsu.2020.08.051.
34.
ZhuYWangBMengQ, et al.Long-term efficacy of endovascular vs open surgical repair for complicated type-B aortic dissection: a single-center retrospective study and meta-analysis. Braz J Med Biol Res2016; 49: e5194.
35.
OkamotoKShimizuHUedaT, et al.Aggressive surgical strategy should be used for the treatment of thoracic aortic disease in patients with end-stage renal disease. Interact Cardiovasc Thorac Surg2011; 12: 384–388. DOI: 10.1510/icvts.2010.255703.
36.
ZhaoYYinHChenY, et al.Restrictive bare stent prevents distal stent graft-induced new entry in endovascular repair of type B aortic dissection. J Vasc Surg2018; 67: 93–103. DOI: 10.1016/j.jvs.2017.04.066.
37.
RedlingerREJr.AhanchiSSPannetonJM. In situ laser fenestration during emergent thoracic endovascular aortic repair is an effective method for left subclavian artery revascularization. J Vasc Surg2013; 58: 1171–1177. DOI: 10.1016/j.jvs.2013.04.045.
38.
BradshawRJAhanchiSSPowellO, et al.Left subclavian artery revascularization in zone 2 thoracic endovascular aortic repair is associated with lower stroke risk across all aortic diseases. J Vasc Surg2017; 65: 1270–1279. DOI: 10.1016/j.jvs.2016.10.111.
